Cargando…
Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives
Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) has caused a pandemic of historic proportions and continues to spread globally, with enormous consequences to human health. Currently there is no vaccine, effective therapeutic or prophylactic. Like other betacoronaviruses, attachm...
Autores principales: | Tandon, Ritesh, Sharp, Joshua S., Zhang, Fuming, Pomin, Vitor H., Ashpole, Nicole M., Mitra, Dipanwita, Jin, Weihua, Liu, Hao, Sharma, Poonam, Linhardt, Robert J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302190/ https://www.ncbi.nlm.nih.gov/pubmed/32577638 http://dx.doi.org/10.1101/2020.06.08.140236 |
Ejemplares similares
-
The structure-activity relationship of the interactions of SARS-CoV-2 spike glycoproteins with glucuronomannan and sulfated galactofucan from Saccharina japonica
por: Jin, Weihua, et al.
Publicado: (2020) -
Safety and Pharmacokinetics of Intranasally Administered Heparin
por: Harris, Hannah M., et al.
Publicado: (2022) -
Safety and Pharmacokinetics of Intranasally Administered Heparin
por: Harris, Hannah M., et al.
Publicado: (2022) -
Comparison of Low-Molecular-Weight Heparins Prepared From Ovine Heparins With
Enoxaparin
por: Chen, Jianle, et al.
Publicado: (2019) -
Structural and kinetic analyses of holothurian sulfated glycans suggest potential treatment for SARS-CoV-2 infection
por: Dwivedi, Rohini, et al.
Publicado: (2021)